Indian top seed Anahat Singh and three male players, Aryaveer Dewan, Yusha Nafees, and Gurveer Singh, have advanced in their respective categories at the World Squash Junior Individual Championships in Ontario, Canada, showcasing a strong start for the Indian contingent.
A ship became stranded near Manori beach in north Mumbai due to very heavy rains and strong winds, leading local police to alert the Indian Coast Guard and other maritime authorities. The area's rocky terrain and adverse weather conditions are hindering relief operations, though no untoward incidents have been reported so far.
Authorities in Gurugram have uncovered a racket involved in the manufacturing and sale of fake Mounjaro (tirzepatide) injections, used for treating diabetes and obesity. Two people have been arrested, and a nationwide alert has been issued to trace counterfeit batches.
Biocon aims to become the world's leading insulin company, capitalising on larger pharmaceutical rivals' strategic shift towards newer, high-margin GLP-1 diabetes therapies. The company plans to expand its insulin presence across 80 markets, focusing on value maximisation and addressing the indispensable need for insulin, particularly for Type-1 and late-stage Type-2 diabetics.
Diksha Dagar will lead a strong Indian contingent at the inaugural MCB Ladies Classic Mauritius, joined by Tvesa Malik, Vani Kapoor, and Hitaashee Bakshi at the Legends Course.
Pharmaceutical major Cipla reported a 3 per cent year-on-year decline in March quarter revenue to Rs 6,541 crore, with net profit falling 55 per cent to Rs 554.6 crore, missing consensus estimates. Despite strong growth in India and Africa, a significant decline in North American sales impacted overall performance, with the company now focusing on new product launches and regulatory filings to drive future gains.
'Any promotional activity carried out under the pretext of disease awareness, influencer engagement, corporate campaigns, or similar activities that create brand recall/product visibility of the prescription shall also be treated as violations.'
'The unregulated marketing has to stop. People are getting recommendations for this from gym trainers, from marriage counsellors -- that is simply unacceptable.' ''There are many ways to lose weight -- eat less, fast, exercise, eat healthy. That is how you lose weight.'
The National Institute of Technology (NIT) Kurukshetra has established a five-member committee to investigate recent student suicide cases on campus. This action follows a series of tragic incidents, including the alleged suicide of a 19-year-old B.Tech student, which sparked protests and raised concerns about student welfare and mental health support within the institution.
Abbott will exclusively distribute and market Extensior in the country, becoming the second company to secure sole distribution rights for Novo's semaglutide portfolio in India, after Emcure Pharma.
Stars are taking the talon fashion to a whole new level!
Novak Djokovic suggested that Serena Williams could see Wimbledon as the ideal venue to return to tennis.
While the introduction of branded generics is likely to accelerate volumes for GLP-1 agonists, value growth may moderate because of price erosion.
Of the donations, 48% is in kind -- such as food, clothing, or other household goods -- followed by cash (44%) and volunteering (30%) with non-profits, religious institutions, or community groups.
Biocon Limited has launched its GLP-1 peptide, liraglutide, for the treatment of diabetes and obesity in the Netherlands, as the biopharmaceutical firm positions itself as a global player in the fast-growing diabetes and obesity market currently dominated by the likes of Novo Nordisk and Eli Lilly.
At the heart of this debate is Section 3(d) of the Patents Act, a safeguard designed to prevent drugmakers from extending monopoly protection through trivial modifications to existing medicines.
'As more patients are prescribed these drugs, intolerance due to gastrointestinal and other side effects will become more visible, leading to higher discontinuation rates.'
For patients, the immediate impact is a reduction in the final cost of therapies that often run into lakhs per month.
The semaglutide patent expiry next year could unleash a wave of generic versions from Indian drugmakers, with prices expected to go lower -- at least 80 per cent.
Emcure Pharmaceuticals on Monday said it saw Poviztra, its newly launched semaglutide brand, as a "long-term" opportunity in India's fast-evolving obesity and cardiometabolic therapy market, even as price competition in the glucagon-like peptide-1 (GLP-1) segment intensified.
The bumper rise is due to the rising demand for the drug and patients' gradual shift towards its higher dosage.
The 23-time Grand Slam champion, who retired from professional tennis in 2022, will headline a multi-year national marketing campaign for GLP-1 drugs, a company spokesperson said.
Priyanka Chopra had a 'much-needed super fun' outing when she attended a Diljit Dosanjh concert in Los Angeles.
'Willingness to try new drugs for obesity management have propelled the growth of this market, which today is almost five times what it was five years ago.'
The 32 year old Indo-Canadian YouTube star wore a mask to express her solidarity for the farmers in India.
'Even though I'm just 31, I feel like I've seen a lot in my life, some voluntarily, some involuntarily.'
Mounjaro is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition.
Prices for Indian consumers are expected to come down significantly from the current Rs 17,000-Rs 26,000 monthly.
Don't shy away from the bold graphic eyeliner!
'I thought helmets would help. So, I took a motorcycle helmet with a polycarbonate visor to WSC.'
The $1.2 billion in-space manufacturing market is expected to grow and be worth more than $20 billion by 2033.
The US-based drug maker Eli Lilly and Company will form strategic drug manufacturing and development alliances with major Indian pharmaceutical companies to tap the opportunities in contract research and manufacturing.
In an Instagram post, the Instagram sensation revealed that she is bisexual.
The Indian-origin Canadian YouTube star joins the long list of celebs using their fame to promote a good cause.
Former Kerala minister M A Baby was elected as the CPI(M) general secretary at the 24th party congress in Madurai. Baby, who was a member of the Rajya Sabha from 1986 to 1998, has been a member of the Politburo since 2012. He succeeds Sitaram Yechury, who passed away last year.
YouTube sensation Lilly Singh gets you in the mood for winter with her latest cover for Vogue.
US-based pharma giants Eli Lilly and company has filed a case against two Indian drug makers, Aurobindo Pharma and Lupin alleging infringement of patent of its anti-depressant drug Cymbalta.
Eli Lilly and Company, the US-based multinational pharmaceutical major, has sued Sun Pharmaceuticals in the US, alleging the company infringed its patent on Gemzar, a blockbuster cancer drug.
